OpenVSafe by OpenVAERS
Search V-safe

TNH-24646-21093

3 vaccinations 10 coded responses 33 check-ins 10 free-text entries 1 call case
Sex
Female
Age at first dose
26-30
ZIP prefix
061 / CT
Registered
2020-12-24
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-23
    Dose 1 — Pfizer-BioNTech
  2. 2020-12-24
    Registered in v-safe
  3. 2020-12-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2020-12-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2020-12-28
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2020-12-30
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-06
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  8. 2021-01-11
    Dose 2 — Pfizer-BioNTech
  9. 2021-01-12
    Survey response — days 1–6 daily, dose 2
    MedDRA: Axillary pain, Lymphadenopathy — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Free text: Axillary lymph node swelling & pain under arm with injection
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-01-12
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to do your normal daily activities
    1 call case(s)
  11. 2021-01-13
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymph node pain, Lymphadenopathy, Skin warm — Feeling: Fair · Site: Pain · Fatigue or tiredness
    Free text: Lymph node in left axilla (received shot in left arm) very swollen, painful, warm to touch
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-01-15
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness
    Free text: Swollen lymph node under injection site arm, resolving
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-01-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  14. 2021-01-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-01-18
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-01-25
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-02-01
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-02-08
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-02-15
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-02-22
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-04-12
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-07-12
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-10-04
    Dose 3 — Pfizer-BioNTech
  24. 2021-10-04
    Health check-in — day 0, dose 3
    Feeling: Fair · Site: Pain · Fatigue or tiredness
    Adult check-in
  25. 2021-10-05
    Survey response — days 1–6 daily, dose 3
    MedDRA: Hyperhidrosis — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Excessive sweating episodes
    MedDRA releases: 2024-11 · check-in free text available
  26. 2021-10-06
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Large swollen axillary lymph node on injection site side
    MedDRA releases: 2024-11 · check-in free text available
  27. 2021-10-07
    Survey response — days 1–6 daily, dose 3
    MedDRA: Injection site reaction, Lymphadenopathy — Feeling: Fair · Site: Pain · Headache, Joint pains, Fatigue or tiredness
    Free text: Improving axillary lymph node swelling on side of injection site
    MedDRA releases: 2024-11 · check-in free text available
  28. 2021-10-08
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain
    Free text: Improving axillary lymph node swelling on injection site side
    MedDRA releases: 2024-11 · check-in free text available
  29. 2021-10-09
    Survey response — days 1–6 daily, dose 3
    MedDRA: Menstrual disorder — Feeling: Good · Site: Pain
    Free text: Menstrual cycle disruption
    MedDRA releases: 2024-11 · check-in free text available
  30. 2021-10-10
    Survey response — days 1–6 daily, dose 3
    MedDRA: Amenorrhoea — Feeling: Good
    Free text: Amenorrhea NOT related to pregnancy
    MedDRA releases: 2024-11 · check-in free text available
  31. 2021-10-11
    Survey response — day 7, dose 3
    MedDRA: Amenorrhoea, Pregnancy — Feeling: Good
    Free text: Amenorrhea NOT related to pregnancy
    MedDRA releases: 2024-11 · check-in free text available
  32. 2021-10-18
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  33. 2021-10-25
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  34. 2021-11-03
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  35. 2021-11-08
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  36. 2021-11-17
    Health check-in — day 42, dose 3
    Feeling: Fair
    Adult check-in
  37. 2022-01-03
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  38. 2022-04-04
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12020-12-23Pfizer-BioNTech
22021-01-11Pfizer-BioNTech
32021-10-04Pfizer-BioNTech No

Call center

1 call center case

1 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 1 — days 1–6 daily, dose 2

2021-01-12

Systemic reaction (other): Axillary lymph node swelling & pain under arm with injection

2021-01-13

Systemic reaction (other): Lymph node in left axilla (received shot in left arm) very swollen, painful, warm to touch

Release 2 — days 1–6 daily, dose 2

2021-01-15

Systemic reaction (other): Swollen lymph node under injection site arm, resolving

Release 10 — days 1–6 daily, dose 3

2021-10-05

Systemic reaction (other): Excessive sweating episodes

2021-10-06

Systemic reaction (other): Large swollen axillary lymph node on injection site side

2021-10-07

Systemic reaction (other): Improving axillary lymph node swelling on side of injection site

2021-10-08

Systemic reaction (other): Improving axillary lymph node swelling on injection site side

2021-10-09

Systemic reaction (other): Menstrual cycle disruption

2021-10-10

Systemic reaction (other): Amenorrhea NOT related to pregnancy

Release 10 — day 7, dose 3

2021-10-11

Systemic reaction (other): Amenorrhea NOT related to pregnancy

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SROAmenorrhoea · · ✓
SROAxillary pain ✓ ✓ ✓
SROHyperhidrosis · · ✓
SROInjection site reaction · · ✓
SROLymph node pain ✓ ✓ ✓
SROLymphadenopathy ✓ ✓ ✓
SROMenstrual disorder · · ✓
SROPregnancy · · ✓
SROSkin warm ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release